Johnson & Johnson Secures FDA Nod for Upgraded VARIPULSE™ Irrigation Rate
Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced U.S. Food and Drug Administration (FDA) approval of an update to the VARIPULSE™ Platform’s irrigation flow rate, reflecting the company’s commitment to the evolution of pulsed field ablation (PFA) innovation following real-world clinical practice. “By learning from real-world experience
